These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

595 related articles for article (PubMed ID: 26550826)

  • 1. Allosteric ligands for the pharmacologically dark receptors GPR68 and GPR65.
    Huang XP; Karpiak J; Kroeze WK; Zhu H; Chen X; Moy SS; Saddoris KA; Nikolova VD; Farrell MS; Wang S; Mangano TJ; Deshpande DA; Jiang A; Penn RB; Jin J; Koller BH; Kenakin T; Shoichet BK; Roth BL
    Nature; 2015 Nov; 527(7579):477-83. PubMed ID: 26550826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, Synthesis, and Characterization of Ogerin-Based Positive Allosteric Modulators for G Protein-Coupled Receptor 68 (GPR68).
    Yu X; Huang XP; Kenakin TP; Slocum ST; Chen X; Martini ML; Liu J; Jin J
    J Med Chem; 2019 Aug; 62(16):7557-7574. PubMed ID: 31298539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. G protein-coupled receptors: Illuminating orphan GPCRs.
    Crunkhorn S
    Nat Rev Drug Discov; 2016 Jan; 15(1):15. PubMed ID: 26718276
    [No Abstract]   [Full Text] [Related]  

  • 4. Differential Roles of Extracellular Histidine Residues of GPR68 for Proton-Sensing and Allosteric Modulation by Divalent Metal Ions.
    Huang XP; Kenakin TP; Gu S; Shoichet BK; Roth BL
    Biochemistry; 2020 Sep; 59(38):3594-3614. PubMed ID: 32865988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DCyFIR: a high-throughput CRISPR platform for multiplexed G protein-coupled receptor profiling and ligand discovery.
    Kapolka NJ; Taghon GJ; Rowe JB; Morgan WM; Enten JF; Lambert NA; Isom DG
    Proc Natl Acad Sci U S A; 2020 Jun; 117(23):13117-13126. PubMed ID: 32434907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategies for the identification of allosteric modulators of G-protein-coupled receptors.
    Burford NT; Watson J; Bertekap R; Alt A
    Biochem Pharmacol; 2011 Mar; 81(6):691-702. PubMed ID: 21184747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging paradigms in GPCR allostery: implications for drug discovery.
    Wootten D; Christopoulos A; Sexton PM
    Nat Rev Drug Discov; 2013 Aug; 12(8):630-44. PubMed ID: 23903222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Allosteric Modulators of G Protein-coupled Receptors.
    Gentry PR; Sexton PM; Christopoulos A
    J Biol Chem; 2015 Aug; 290(32):19478-88. PubMed ID: 26100627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacology of Free Fatty Acid Receptors and Their Allosteric Modulators.
    Grundmann M; Bender E; Schamberger J; Eitner F
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33578942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The evolution and mechanism of GPCR proton sensing.
    Rowe JB; Kapolka NJ; Taghon GJ; Morgan WM; Isom DG
    J Biol Chem; 2021; 296():100167. PubMed ID: 33478938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of new GPCR ligands to illuminate new biology.
    Roth BL; Irwin JJ; Shoichet BK
    Nat Chem Biol; 2017 Nov; 13(11):1143-1151. PubMed ID: 29045379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allosteric Modulators of the Class A G Protein Coupled Receptors.
    Tschammer N
    Adv Exp Med Biol; 2016; 917():185-207. PubMed ID: 27236557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synoptic pharmacology: Detecting and assessing the pharmacological significance of ligands for orphan receptors.
    Kenakin TP
    Pharmacol Res; 2016 Dec; 114():284-290. PubMed ID: 26804250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bitopic Ligands and Metastable Binding Sites: Opportunities for G Protein-Coupled Receptor (GPCR) Medicinal Chemistry.
    Fronik P; Gaiser BI; Sejer Pedersen D
    J Med Chem; 2017 May; 60(10):4126-4134. PubMed ID: 28140580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allosteric modulators of rhodopsin-like G protein-coupled receptors: opportunities in drug development.
    Müller CE; Schiedel AC; Baqi Y
    Pharmacol Ther; 2012 Sep; 135(3):292-315. PubMed ID: 22728155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opportunities and Challenges in the Discovery of Allosteric Modulators of GPCRs.
    Bartuzi D; Kaczor AA; Matosiuk D
    Methods Mol Biol; 2018; 1705():297-319. PubMed ID: 29188568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural Basis for Allosteric Modulation of Class B G Protein-Coupled Receptors.
    Wootten D; Miller LJ
    Annu Rev Pharmacol Toxicol; 2020 Jan; 60():89-107. PubMed ID: 31454292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computational Advances for the Development of Allosteric Modulators and Bitopic Ligands in G Protein-Coupled Receptors.
    Feng Z; Hu G; Ma S; Xie XQ
    AAPS J; 2015 Sep; 17(5):1080-95. PubMed ID: 25940084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GPCR Signaling Measurement and Drug Profiling with an Automated Live-Cell Microscopy System.
    Greenwald E; Posner C; Bharath A; Lyons A; Salmerón C; Sriram K; Wiley SZ; Insel PA; Zhang J
    ACS Sens; 2023 Jan; 8(1):19-27. PubMed ID: 36602887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allosteric modulation of GPCRs: From structural insights to in silico drug discovery.
    Persechino M; Hedderich JB; Kolb P; Hilger D
    Pharmacol Ther; 2022 Sep; 237():108242. PubMed ID: 35863587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.